Summary We have investigated the occurrence of attenuated extracolonic manifestations (AEMs) of familial adenomatous polyposis (FAP) in patients with non-polyposis colorectal cancer. In a prospective case-control study, we observed that significantly more colorectal cancer patients exhibited AEM 1985a, b; Houlston et al., 1992; Dunlop, 1983; Hunt et al., 1994). These features, congenital hypertrophy of the retinal pigment epithelium (CHRPE) and mandibular osteomas, occur in 90% and 75% respectively of patients with classical FAP (Utsunomiya and Nakamura, 1975; Bulow et al., 1984; Traboulsi et al., 1987; Berk et al., 1988; Chapman et al., 1989; Giardiello et al., 1991; Hodgson et al., 1994; Wallis et al., 1994) . The finding of such extracolonic features in patients with non-FAP colorectal cancer is of considerable interest because of the central, and probably initiating, role of the gene for FAP (APC) in colorectal tumorigenesis. Constitutional and heterozygous mutation of the APC gene is responsible for the FAP syndrome (Groden et al., 1991; Nishishio et al., 1991; Nagase and Nakamura, 1993) , while a high proportion of non-FAP colorectal adenomas and cancers have somatic APC mutations (Powell et al., 1992; Ichii et al., 1993; Nagasse and Nakamura, 1993). Inactivating APC mutations have also been noted in dysplastic aberrant crypt foci Smith et al., 1984), which are believed to be the very earliest histological manifestation of colorectal neoplasia.
An association has been reported between sporadic colorectal cancer and two clinical features that are normally considered to be extracolonic manifestations of the autosomal dominant syndrome familial adenomatous polyposis (FAP) (Sondergaard et al., 1993; 1985a, b; Houlston et al., 1992; Dunlop, 1983; Hunt et al., 1994) . These features, congenital hypertrophy of the retinal pigment epithelium (CHRPE) and mandibular osteomas, occur in 90% and 75% respectively of patients with classical FAP (Utsunomiya and Nakamura, 1975; Bulow et al., 1984; Traboulsi et al., 1987; Berk et al., 1988; Chapman et al., 1989; Giardiello et al., 1991; Hodgson et al., 1994; Wallis et al., 1994) . The finding of such extracolonic features in patients with non-FAP colorectal cancer is of considerable interest because of the central, and probably initiating, role of the gene for FAP (APC) in colorectal tumorigenesis. Constitutional and heterozygous mutation of the APC gene is responsible for the FAP syndrome (Groden et al., 1991; Nishishio et al., 1991; Nagase and Nakamura, 1993) , while a high proportion of non-FAP colorectal adenomas and cancers have somatic APC mutations (Powell et al., 1992; Ichii et al., 1993; Nagasse and Nakamura, 1993) . Inactivating APC mutations have also been noted in dysplastic aberrant crypt foci Smith et al., 1984) , which are believed to be the very earliest histological manifestation of colorectal neoplasia.
The available data suggest that the extracolonic manifestations of FAP, which we term attenuated extracholonic manifestations (AEMs), occur particularly in colorectal cancer patients with a family history of the disease (Sondergaard et al., 1985b; Houlston et al., 1992; Hunt et al., 1994) . Thus we wished to determine whether there was any link with hereditary non-polyposis colorectal cancer (HNPCC), which is responsible for 2-5% of all colorectal cancer cases. HNPCC gene carriers develop few colorectal adenomas but are at high risk of colorectal cancer, particularly of the right colon, as well as other cancers Jass et al., 1994) . Causative germline mutations in the DNA mismatch repair (MMR) genes hMSH2, hMLHI, hPMSJ and hPMS2 (Liu et al., 1996) have been identified in HNPCC families. Such mutations result in defective MMR (Parsons et al., 1993; Umar et al., 1994) , manifest as instability of repetitive DNA in tumours (Ionov et al., 1993; Aaltonen et al., 1993; Thibodeau et al., 1993; Lothe et al., 1993; Aaltonen et al., 1994; Bhattacharyya et al., 1994; Liu et al., 1995a) and termed replication error (RER) tumour phenotype. Somatic mutations in GTBP, another MMR gene, are responsible for the RER phenotype in some tumours (Drummond et al., 1995; Palombo et al., 1995; Papadopolous et al., 1995) . However, germline GTBP mutations have not been identified in any of the highly penetrant HNPCC families analysed so far (Papadopoulos et al., 1995) , although GTBP involvement in low-penetrance colorectal cancer susceptibility has not been excluded. The RER tumour phenotype is present in about 15% of sporadic colorectal cancers (Ionov et al., 1993; Aaltonen et al., 1993; Thidodeau et al., 1993; Lothe et al., 1993; Liu et al., 1995a) , 80-90% of which are in the proximal colon (Ionov et al., 1993; Thibodeau et al., 1993; Lothe et al., 1993 Retinal and mandible examinations Bilateral retinal examination was performed in 167 of the patients and 160 of the controls described above by indirect ophthalmoscopy (Model Omega 100, Heine, Germany), using a Nikon 20D lens after mydriasis by one of two opthalmologists. All efforts were made to ensure that the ophthalomologists were unaware of the subjects' health status and did not discuss recent operations or family history with the patients. Retinal lesions were documented on fundal charts and photographed. Thirty patients (with and without CHRPE) were assessed by both ophthalomologists, and this ensured inter-observer reproducibility. The diagnostic criteria we used for retinal pigmentation in non-polyposis colorectal cancer patients were the same as those taken as diagnostic of CHRPE in familial adenomatous polyposis, namely: > 1 pigmented lesions with depigmented halo; >1 pigmented lesions over one optic disc diameter; > 3 small bilateral pigmented lesions without a halo or >4 small unilateral lesions (Traboulsi et al., 1987; Chapman et al., 1988; Berk et al., 1988; Giardello et al., 1991; Hodgson et al., 1994; Wallis et al., 1994) . Because of the variety of CHRPE lesions, we devised a scoring system derived from the relative importance ascribed to each feature in previous FAP studies. Pigmented haloed lesions and lesions > 1 disc diameter scored 5: small lesions scored 1 and the total score for bilateral lesions was doubted.
Posteroanterior, occlusal and pantomographic radiographic views of the mandible were obtained using Roentgen 501, Siemens Heliodent MD and Morita Panex EC machines respectively on 163 patients and 159 controls, with immediate reveiw and further oblique or intra-oral views for inconclusive cases. Radiographs were interpreted independently on two separate occassions by a radiologist and an oral surgeon blinded to the subjects' disease status. Osteomas were defined as discrete homogeneous radio-opaque areas >2 mm in diameter-with no surrounding radiolucent zone, distinct from the teeth and apices (Bulow et al., 1984; Sondergaard et al., 1985a, b; .
APC gene screening
We wished to determine whether any of our findings could be explained on the basis of the constitutional and heterozygous APC mutations associated with a weakly expressed form of FAP. Hence, we searched for truncating APC mutations in all coding sequences from exon 9 to the termination signal at the 3' end of exon 15, which includes all regions of APC known to be associated with expression of the CHRPE phenotype in FAP (Olschwang et al., 1993) . Peripheral blood from all 33 patients exhibiting AEM was screened by an in vitro synthesised protein assay (IVSP) (Powell et al., 1993; Prosser et al., 1994) for translation-terminating APC gene mutations and by heteroduplex analysis (Prosser et al., 1994; Keen et al., 1991) for each of exons 9 -14. Positive control samples from FAP patients and manufacturer's control reactions were always run in parallel. The APC gene was amplified by polymerase chain reaction (PCR) in overlapping fragments from DNA and RNA purified from peripheral blood with forward PCR primers, including signals for transcription and translation. RNA was available for five patients in whom exons 1 -14 were analysed by IVSP of reverse-transcribed complementary DNA as described (Prosser et al., 1994) . Resultant PCR products were used in a coupled transcription -translation reaction (Promega, UK) generating radiolabelled synthetic polypeptide sequences, which were analysed by SDS -PAGE followed by autoradiography. Approximately 500 bp of the most 5' part of APC exon 15 was analysed by heteroduplex analysis in overlapping fragments using the PCR primers as described (Groden et al., 1991) to exclude any mutations occurring in the most 5' region of exon 15, which would result in such a short peptide in the IVSP assay that a mutation could be masked. Exons 9 -14 were analysed separately in all 33 patients by heteroduplex analysis of PCR-amplified leucocyte DNA with electrophoresis on MDETM gels (JT Baker, USA) and ethidium bromide staining (Keen et al., 1991) . Any heteroduplex variants between normal and tumour DNA were reamplified and sequenced.
Tumour DNA instability analysis As microsatellite DNA instability (RER phenotype) has been observed in colorectal cancers and is the result of inherited or of somatic mutation in one of the DNA mismatch repair genes Parsons et al., 1993; Liu et al., 1995a; Papadopoulos et al., 1995) , we wished to correlate our findings of the AEM phenotype with such tumour DNA instability. We were able to obtain fresh surgical resection specimens form 33 of the patients recruited to the study at one of the participating hospitals (12 with and 21 without AEMs). DNA was purified from tumour and normal mucosa and RER status assessed by comparison of PCR-amplified paired tumour/control DNAs at six PCR-amplified (CA), repeat marker loci: D2S 123, D2S1 19, D3S1293, D8S282, D13S160 (Gyapay et al., 1994) and at a polyadenine tract; BAT40 (Liu et al., 1995b) . Formamidedenatured PCR products were electrophoresed on 6% denaturing acrylamide gels in 0.5 x TBE buffer and silverstained (Bassam et al., 1991) . All aberrant banding patterns indicative of RER phenotype were confirmed by repeat analyses. Tumours were considered to exhibit the RER phenotype when band alterations were present at two or more loci when compared with matched control DNA as described previously (Liu et al., 1995a, b Table I . Although we assessed a reasonably large study population at the outset and the differences that we observed do reach statistical significance, it should be noted that the numbers in some of the subcategories are small. Nonetheless, there does appear to be an association of AEMs with colorectal cancer and, within the cancer group, with proximal tumour location, with an RER phenotype and with a family history of HNPCC.
A representative case of multiple small patches of retinal pigmentation is shown in Figure 1 . Although the features were similar to that seen in FAP, they were of lower One of the control subjects with striking retinal pigmentation had a father and aunt with colorectal cancer. In the control group as a whole, in which we were able to confirm a negative family history, CHRPE prevalence was substantially less than in the colorectal cancer patients (4.9% vs 19.5%, P<0.02).
Osteoma prevalence was almost 3-fold greater in patients than in control subjects, although osteoma prevalence alone did not reach statistical significance owing to the small numbers. Thirteen of 163 patients (8.0%) and 5 of 159 (3%) controls undergoing mandibular radiography had > 1 osteoma. An orthopantomogram from a patient with colorectal cancer is shown in Figure 3 .
APC gene mutation analysis There were no constitutional truncating APC mutations identified in peripheral blood DNA for RNA in 33 patients with AEM (data not shown). The combination of IVSP assays of exon 15 and heteroduplex analysis of exons 9-14 for all patients, along with IVSP analysis of cDNA for exons 1 -14 in five patients, excludes the presence of heterozygous truncating APC mutations in those patients with extracolonic features of FAP. Hence, unrecognised cases of FAP cannot explain these observations. Tumour clinicopathological characteristics There were 172 carcinomas in 169 patients, three patients (1.8%) having synchronous tumours. There were 14 Dukes' Figure 1 Fundal photograph of one sector of the retina in a patient with colorectal cancer and retinal pigmentation (arrowed). There are several small pigmented areas in this and other retinal quadrants and also a small number in the contralateral eye. 
Discussion
The results of this case -control study establish the association between colorectal cancer and extracolonic features normally associated with the autosomal dominant syndrome of FAP. Our observations support and extend previous reports that have noted extracolonic manifestations of FAP in patients with colorectal cancer (Sondergaard et al., 1985a; Houlston et al., 1992; Hunt et al., 1994 ). An association between sporadic colorectal cancer and mandibular osteomas has been reported in Scandinavia (Sondergaard et al., 1985a; , and an excess of CHRPE in selected patients with familial non-polyposis colorectal cancer has been reported in the UK (Houlston et al., 1992; Hunt et al., 1994) . Our findings accord well with UK study of Hunt et al. (1994) , in which a lower patient prevalence of mandibular osteomas than that reported in Scandinavia (Sondergaard et al., 1985a; , 1993) and so cannot explain our findings. Another explanation that seems improbable concerns the possibility that constitutional APC mutations resulting only in amino acid alterations could be responsible for both AEM and colorectal cancer susceptibility. However, mutations resulting in protein truncation or in substantial reduction in intracellular APC protein concentration is an absolute requirement for the development of FAP (Nagase and Nakamura, 1993; Powell et al., 1993) . In addition, truncating mutations are found almost universally in sporadic colorectal carcinomas (Nagase and Nakamura, 1993; Powell et al., 1992) , adenomas (Powell et al., 1992; Ichii et al., 1993) and even in some aberrant crypt foci Smith et al., 1994) . This argues strongly that mis-sense APC mutations are not responsible for our findings of an association of colorectal neoplasia and AEMs. Next, we determined the proportion of patients with AEMs that exhibited genetic instability, as mutations in mono-and dinucleotide anonymous repeat sequence mutations have been observed in normal tissues in a subset of HNPCC patients with a tumour RER phenotype . Although the numbers of cases in some of the subcategories were small, we did observe a statistically significant association between AEMs and a family history of HNPCC, a proximal tumour preponderance and tumour DNA instability, all of which are very suggestive of the involvement of defective DNA mismatch repair. The fact that not all patients with AEMs had a tumour with the RER phenotype may be due to failure of our RER assay to identify subtle DNA repair defects resulting from particular mutations in the known MMR genes hMSH2, hMLHI, hPMSJ and hPMS2. It is also possible that defects within other genes known to participate in DNA mismatch repair may induce a weak, constitutional mutator phenotype. One such obvious candidate is GTBP, for which no germline mutations have been found in large classical HNPCC families (Papadopoulos et al., 1995) , but low-penetrance mutations in GTBP may be responsible for a proportion of apparently sporadic colorectal cancer. Several other genes homologous with the known MMR genes are also currently under investigation by a number of research groups. Such genes may result in a low level of genetic instability, which could explain the lack of tumour RER phenotype in all patients with AEMs.
There is already evidence to support the notion that defective DNA mismatch repair can result in a constitutional mutator phenotype and that such a phenotype results in predisposition to cancer. Genetic instability has been observed in normal tissue and sperm from transgenic mice with homozygous inactivation of MLHJ and MSH2 (de Wind et al., 1995; Baker et al., 1995 (Chao et al., 1993) .
Mosaicism may explain why the retinal and mandibular changes that we observed in this study group were more subtle that those seen in FAP patients. Despite every cell carrying a mutant APC alllele in FAP patients, only a small proportion of cells contribute to retinal and osseous lesions. Indeed, even in the colorectum, there are some normal cells; and some FAP patients have relatively few colonic adenomas. Our proposed model implies that only a small proportion of retinal and mandibular cells carry a mutant APC allele, and so the number and extent of the retinal, osseous and indeed colorectal lesions would be expected to be proportionately less. Such mosaicism could represent a mechanism by which mutations in expressed genes involved in cancer development could accumulate in stem cells in adult, or even in intrauterine, life without a requirement for induction of clonal expansion. Thus, the degree of mandibular and retinal changes would be indicative of the level of mosaicism and perhaps even cancer risk. It is intriguing that two of the three patients with synchronous tumours had AEM while the third also had two small CHRPE lesions. Definitive proof of somatic APC mosaicism in patients with AEM will require further extensive detailed molecular analysis.
Although we favour APC mutational mosaicism as the best interpretation of our findings, other possible hypotheses should be considered. The features noted here could represent phenocopies of FAP manifestations or be due to constitutional down-regulation of APC by a modifier gene such as Mom I (Dietrich et al., 1993) . However, these interpretations do not addresss our observations of a familial tendency, the greater proportion of patients with right-sided tumours exhibiting AEMs and the association of AEM with tumour DNA instability. The strong family history of colorectal cancer in a control subject with marked retinal pigmentation is also suggestive of a real association between AEM and familial cancer susceptibility.
In conclusion, we have demonstrated an excess of extracolonic features of FAP in an unselected patient group with colorectal cancer but without the colonic polyposis characteristic of FAP or a constitutional mutation in one allele of the APC gene. Although the relationship is not exclusive, the AEM phenotype does appear to be linked with proximal tumour location, the RER tumour phenotype and with a family history of HNPCC, all of which are known to be associated with defective DNA mismatch repair. Further studies are required to investigate these novel observations and to elucidate this potential role for MMR deficiency in cancer predisposition. In addition, follow-up of healthy individuals found to have AEM in ths study may determine whether there is indeed an associated increase in colorectal cancer risk and whether the presence of AEM merits colonoscopic surveillance.
